Cart
sales@molnova.com
Eprodisate disodium
CAS No. 36589-58-9
Eprodisate disodium( Eprodisate Disodium | Eprodisate sodium | Kiacta )
Catalog No. M14258 CAS No. 36589-58-9
Eprodisate Disodium is the orally available disodium salt form of Eprodisate, a negatively charged sulfonated inhibitor of fibrillogenesis, that can be used in the treatment of amyloid A (AA) amyloidosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 30 | In Stock |
|
| 100MG | 42 | In Stock |
|
| 200MG | 61 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEprodisate disodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionEprodisate Disodium is the orally available disodium salt form of Eprodisate, a negatively charged sulfonated inhibitor of fibrillogenesis, that can be used in the treatment of amyloid A (AA) amyloidosis.
-
DescriptionEprodisate Disodium is the orally available disodium salt form of Eprodisate, a negatively charged sulfonated inhibitor of fibrillogenesis, that can be used in the treatment of amyloid A (AA) amyloidosis.
-
In Vitro——
-
In Vivo——
-
SynonymsEprodisate Disodium | Eprodisate sodium | Kiacta
-
PathwayOthers
-
TargetOther Targets
-
RecptorSAA
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number36589-58-9
-
Formula Weight248.19
-
Molecular FormulaC3H6Na2O6S2
-
Purity>98% (HPLC)
-
SolubilitySoluble in Water
-
SMILESO=S(CCCS(=O)([O-])=O)([O-])=O.[Na+].[Na+]
-
Chemical Name1,3-Propanedisulfonic acid, disodium salt
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bayes M, et al. Methods Find Exp Clin Pharmacol. 2007 Apr;29(3):231-45.
molnova catalog
related products
-
(S)-(+)-Carvone
(S)-(+)-Carvone is the main constituent of caraway oil and pineapple seed oil.
-
Divarasib
Divarasib (GDC-6036) (GDC-6036) is an investigational, oral, high-potency and selective KRAS G12C inhibitor with an IC50 of < 0.01 μM.
-
NLS-StAx-h
Wnt inhibitor (IC50 = 1.4 μM). Stapled peptide inhibitor of oncogenic Wnt signaling. Inhibits β-catenin-transcription factor interactions. Inhibits proliferation and migration of colorectal cancer cells. Cell permeable.
